Galaxy, re have i bothered to do my research on the people....seriously, do you really think i am the kind of guy who doesn't do research??
Let me put it in a way that's relevant, excepting extreme cases, I couldn't give a flyish fish about past achievement other to judge a persons character/integrity. That is the only reason I look at historical performance and the reason that I do so is because each ore-body is different and each company has a different set of circumstances. The only thing that carries through to each project is a person's personality.
Does anyone know how many shares the Directors have in this company? Does anyone know what the face value of the Directors interests are in the bonds that have to be repaid in February 2017?
Understanding where management stand to gain the most will give you an insight into how they will deal with the bondholders in Feb next year...i.e. If management have a huge position in the bonds then it may well be in their interest to convert the bonds into shares at .005 cents per share or less....i'm not concluding, i'm just painting a possible scenario....
- Forums
- ASX - By Stock
- KBL
- Ann: Revenue Generation Recommences-KBL.AX
Ann: Revenue Generation Recommences-KBL.AX, page-135
-
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KBL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online